OncoBrain AI Evaluated for Oncology Treatment Planning Across Multiple Specialties
OncoBrain, a novel AI platform, has been assessed for its capability to create oncology treatment plans across various specialties. This system integrates general large language models with a cancer-specific graph retrieval-augmented generation layer and utilizes a gold-standard treatment-plan corpus as its long-term memory. Additionally, it features a model-agnostic safety layer (CHECK) for detecting and mitigating hallucinations. Researchers conducted evaluations on clinician-enriched case summaries spanning gynecologic, genitourinary, neuro-oncology, gastrointestinal/hepatobiliary, and hematologic malignancies. Three groups of clinicians assessed 173 cases using a standardized 16-item tool, with subspecialist oncologists examining 50 cases. This study aims to alleviate the cognitive load on clinicians managing genomics, staging, radiology, pathology, and evolving guidelines, especially in community settings where over 80% of U.S. cancer care occurs and survival rates lag behind those at academic institutions. This research marks a preliminary move towards OGI (Oncology General Intelligence).
Key facts
- OncoBrain is an AI clinical reasoning platform for oncology treatment-plan generation.
- It combines general-purpose LLMs with a cancer-specific graph retrieval-augmented generation layer.
- It uses a gold-standard treatment-plan corpus as long-term memory.
- It includes a model-agnostic safety layer (CHECK) for hallucination detection and suppression.
- Evaluations covered gynecologic, genitourinary, neuro-oncology, gastrointestinal/hepatobiliary, and hematologic malignancies.
- Three clinician groups evaluated 173 cases using a 16-item instrument.
- Subspecialist oncologists reviewed 50 cases.
- More than 80% of U.S. cancer care is delivered in community settings.
Entities
Institutions
- OncoBrain
Locations
- United States